Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick®): A Review in Asthma
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-018-0644-2
Abstract: The novel, easy-to-use, breath-actuated fluticasone propionate/salmeterol multidose dry powder inhaler (MDPI) (AirDuo RespiClick®) was recently approved in the USA for twice-daily treatment of asthma in patients aged ≥ 12 years. This inhaled corticosteroid (ICS) and long-acting… read more here.
Keywords: fluticasone propionate; propionate salmeterol; salmeterol mdpi; mdpi ... See more keywords